|
Sign In to gain access to subscriptions and/or personal tools.
|
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations
M G Sabbadini
University of Milano, Milano, Italy; HS Raffaele Scientific Institute, Milano, Italy; Divisione di Medicina Seconda, HS Raffaele, Via Olgettina 60, 20132, Milano, Italy
A A Manfredi
E Bozzolo
L Ferrario
HS Raffaele Scientific Institute, Milano, Italy
C Rugarli
University of Milano, Milano, Italy; HS Raffaele Scientific Institute, Milano, Italy
R Scorza
University of Milano, Milano, Italy; Scientific Institute H Maggiore, Milano, Italy
L Origgi
M Vanoli
Scientific Institute H Maggiore, Milano, Italy
O Gambini
L Vanzulli
D Croce
HS Raffaele Scientific Institute, Milano, Italy
A Campana
Biomedical Sciences Institute, HS Paolo, University Department of Mental Health, Milano, Italy
C Messa
F Fazio
University of Milano, Milano, Italy; HS Raffaele Scientific Institute, Milano, Italy
A Tincani
G Anzola
R Cattaneo
A Padovani
R Gasparotti
Spedali Civili and University of Brescia, Brescia, Italy
R Gerli
R Quartesan
M Piccirilli
University of Perugia, Perugia, Italy
A Farsi
E Emmi
M Domeneghetti
C Piccini
L Massacesi
A Pupi
M De Cristoforis
University of Firenze, Firenze, Italy
M Danieli
M Candela
P Fraticelli
M Bartolini
U Salvolini
G Danieli
University of Ancona, Ancona, Italy
A Passaleva
University of Firenze, Firenze, Italy
Objective: To verify whether features of CNS involvement can be detected in SLE patients without overt neuropsychiatric manifestations.
Methods: 114 SLE patients who had never received a diagnosis of neuropsychiatric lupus (never NPSLE) were studied and compared to 65 SLE patients with known neuropsychiatric involvement (NPSLE). The study relied on evaluation of neurocognitive functions by means of a battery of neuropsychological tests, on psychiatric and neuropsychological assessments and on neuroimaging studies (computed tomography, magnetic resonance, single photon emission computed tomography (SPECT)).
Results: Clinical features, including disease duration/activity and pharmacological therapy, of never-NPSLE and NPSLE patients were similar. Short-term and long-term memory, visuo-spatial and verbal information processing were similarly compromised in never-NPSLE and in NPSLE patients; only attention was significantly more compromised in NPSLE patients. Psychiatric morbidity was higher than expected in never-NPSLE patients, although less than in the control neuropsychiatric group. Ischemic lesions, multiple small high intensity lesions and cortical atrophy, detected by CT and MR scans, as well as abnormal SPECT were also frequently detected in never NPSLE patients. Interestingly, left parietal and occipital area hypoperfusion by SPECT was significantly more frequent in the patients with impaired visuo-spatial intelligence and short-term memory.
Conclusions: Most abnormalities detected by available diagnostic tools and characteristics of neuropsychiatric SLE are also present in non-symptomatic patients. They may derive from an unexpected widespread involvement of the CNS and are not per se sufficient, in the absence of clinical manifestations, for a diagnosis of neuropsychiatric SLE.
Key Words: systemic lupus erythematosus central nervous system SPECT neurocognitive functions
Lupus, Vol. 8, No. 1,
11-19 (1999)
DOI: 10.1191/096120399678847344

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D Paran, I Litinsky, I Shapira-Lichter, S Navon, T Hendler, D Caspi, and E Vakil
Impaired memory and learning abilities in patients with systemic lupus erythematosus as measured by the Rey Auditory Verbal Learning Test
Ann Rheum Dis,
June 1, 2009;
68(6):
812 - 816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Tatsukawa, K Ishii, M Haranaka, M Kumagi, I Hino, and H Yoshimatsu
Evaluation of average amount of cerebral blood flow measured by brain perfusion index in patients with neuropsychiatric systemic lupus erythematosus.
Lupus,
June 1, 2005;
14(6):
445 - 449.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E Kozora, M C Ellison, J A Waxmonsky, F S Wamboldt, and T L Patterson
Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus
Lupus,
May 1, 2005;
14(5):
363 - 372.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Y. McLaurin, S. L. Holliday, P. Williams, and R. L. Brey
Predictors of cognitive dysfunction in patients with systemic lupus erythematosus
Neurology,
January 25, 2005;
64(2):
297 - 303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O Nived, G Sturfelt, M H Liang, and P De Pablo
The ACR nomenclature for CNS lupus revisited
Lupus,
December 1, 2003;
12(12):
872 - 876.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S D Denburg and J A Denburg
Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus
Lupus,
December 1, 2003;
12(12):
883 - 890.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S L Holliday, M G Navarrete, D Hermosillo-Romo, C R Valdez, A R Saklad, A Escalante, and R L Brey
Validating a computerized neuropsychological test battery for mixed ethnic lupus patients
Lupus,
September 1, 2003;
12(9):
697 - 703.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Oku, T. Atsumi, S. Furukawa, T. Horita, Y. Sakai, S. Jodo, Y. Amasaki, K. Ichikawa, O. Amengual, and T. Koike
Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement
Rheumatology,
June 1, 2003;
42(6):
773 - 777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jonsen, A. A. Bengtsson, O. Nived, B. Ryberg, and G. Sturfelt
Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality
Rheumatology,
November 1, 2002;
41(11):
1308 - 1312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. V. C. Portela, J. C. T. Brenol, R. Walz, M. Bianchin, A. B. L. Tort, U. P. Canabarro, S. Beheregaray, J. A. Marasca, R. M. Xavier, E. C. Neto, et al.
Serum S100B Levels in Patients with Lupus Erythematosus: Preliminary Observation
Clin. Vaccine Immunol.,
January 1, 2002;
9(1):
164 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Mathieu, G Sanna, A Mameli, C Pinna, A Vacca, A Cauli, G Passiu, and M Piga
Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus
Lupus,
January 1, 2002;
11(1):
52 - 56.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G Sanna, M Piga, J W Terryberry, M T Peltz, S Giagheddu, L Satta, A Ahmed, A Cauli, C Montaldo, G Passiu, et al.
Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations
Lupus,
October 1, 2000;
9(8):
573 - 583.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R Hilker, A Thiel, C Geisen, and J Rudolf
Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome
Lupus,
May 1, 2000;
9(4):
311 - 316.
[Abstract]
[PDF]
|
 |
|
|
|